Melatonin attenuates cisplatin-induced HepG2 cell death via the regulation of mTOR and ERCC1 expressions

World Journal of Hepatology

Volumn 6, Issue 4, 2014, Pages 230-242

  Bennukul, Kangsadarn ^a   Numkliang, Sucha ^a   Leardkamolkarn, Vijittra ^a,b  

^a Toxicology Graduate Programme Faculty of Science Mahidol University ^*  (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Autophagy; Cisplatin; Excision repair cross complementary 1; Hepatocellular carcinoma; Mammalian target of rapamycin; Melatonin

Indexed keywords

EID: 84901233805     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v6.i4.230     Document Type: Article

References (42)

1. Arslan C, Ozdemir E, Dogan E, Ozisik Y, Altundag K. Secondary hematological malignancies after treatment of non-metastatic breast cancer. J BUON 2011; 16: 744-750 [PMID: 22331732]
2. Gerets HH, Tilmant K, Gerin B, Chanteux H, Depelchin BO, Dhalluin S, Atienzar FA. Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol Toxicol 2012; 28: 69-87 [PMID: 22258563 DOI: 10.1007/ s10565-011-9208-4]
3. Varan A, Batu A, Cila A, Soylemezoglu F, Balci S, Akalan N, Zorlu F, Akyüz C, Kutluk T, Büyükpamukçu M. Optic glioma in children: a retrospective analysis of 101 cases. Am J Clin Oncol 2013; 36: 287-292 [PMID: 22547006 DOI: 10.1097/ COC.0b013e3182467efa]
4. Noguchi K, Yokoo H, Nakanishi K, Kakisaka T, Tsuruga Y, Kamachi H, Matsushita M, Kamiyama T. A long-term survival case of adult undifferentiated embryonal sarcoma of liver. World J Surg Oncol 2012; 10: 65 [PMID: 22540346 DOI: 10.1186/1477-7819-10-65]
5. Jordan P, Carmo-Fonseca M. Molecular mechanisms involved in cisplatin cytotoxicity. Cell Mol Life Sci 2000; 57: 1229-1235 [PMID: 11028915]
6. Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 2005; 4: 307-320 [PMID: 15789122 DOI: 10.1038/nrd1691]
7. Cassone VM. Effects of melatonin on vertebrate circadian systems. Trends Neurosci 1990; 13: 457-464 [PMID: 1701579]
8. Shochat T, Haimov I, Lavie P. Melatonin--the key to the gate of sleep. Ann Med 1998; 30: 109-114 [PMID: 9556097]
9. Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ. A review of the multiple actions of melatonin on the immune system. Endocrine 2005; 27: 189-200 [PMID: 16217132]
10. Cheung RT. The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion. J Pineal Res 2003; 34: 153-160 [PMID: 12614473 DOI: 10.1034/j.1600- 079X.2003.00034.x]
11. Park KH, Kang JW, Lee EM, Kim JS, Rhee YH, Kim M, Jeong SJ, Park YG, Kim SH. Melatonin promotes osteoblastic differentiation through the BMP/ERK/Wnt signaling pathways. J Pineal Res 2011; 51: 187-194 [PMID: 21470302 DOI: 10.1111/ j.1600-079X.2011.00875.x]
12. Tekbas OF, Ogur R, Korkmaz A, Kilic A, Reiter RJ. Melatonin as an antibiotic: new insights into the actions of this ubiquitous molecule. J Pineal Res 2008; 44: 222-226 [PMID: 18289175 DOI: 10.1111/j.1600-079X.2007.00516.x]
13. Korkmaz A, Reiter RJ, Topal T, Manchester LC, Oter S, Tan DX. Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med 2009; 15: 43-50 [PMID: 19011689 DOI: 10.2119/molmed.2008.00117]
14. Sánchez-Hidalgo M, Lee M, de la Lastra CA, Guerrero JM, Packham G. Melatonin inhibits cell proliferation and induces caspase activation and apoptosis in human malignant lymphoid cell lines. J Pineal Res 2012; 53: 366-373 [PMID: 22582944 DOI: 10.1111/j.1600-079X.2012.01006.x]
15. Shiu SY, Leung WY, Tam CW, Liu VW, Yao KM. Melatonin MT1 receptor-induced transcriptional up-regulation of p27(Kip1) in prostate cancer antiproliferation is mediated via inhibition of constitutively active nuclear factor kappa B (NF-?B): potential implications on prostate cancer chemoprevention and therapy. J Pineal Res 2013; 54: 69-79 [PMID: 22856547 DOI: 10.1111/j.1600-079X.2012.01026.x]
16. Cabrera J, Negrín G, Estévez F, Loro J, Reiter RJ, Quintana J. Melatonin decreases cell proliferation and induces melanogenesis in human melanoma SK-MEL-1 cells. J Pineal Res 2010; 49: 45-54 [PMID: 20459460 DOI: 10.1111/j.1600- 079X.2010.00765.x]
17. Martín-Renedo J, Mauriz JL, Jorquera F, Ruiz-Andrés O, González P, González-Gallego J. Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. J Pineal Res 2008; 45: 532-540 [PMID: 19012662 DOI: 10.1111/ j.1600-079X.2008.00641.x]
18. Jou MJ, Peng TI, Yu PZ, Jou SB, Reiter RJ, Chen JY, Wu HY, Chen CC, Hsu LF. Melatonin protects against common deletion of mitochondrial DNA-augmented mitochondrial oxidative stress and apoptosis. J Pineal Res 2007; 43: 389-403 [PMID: 17910608 DOI: 10.1111/j.1600-079X.2007.00490.x]
19. Liu L, Xu Y, Reiter RJ. Melatonin inhibits the proliferation of human osteosarcoma cell line MG-63. Bone 2013; 55: 432-438 [PMID: 23470834 DOI: 10.1016/j.bone.2013.02.021]
20. Sanchez-Barcelo EJ, Mediavilla MD, Alonso-Gonzalez C, Reiter RJ. Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation. Expert Opin Investig Drugs 2012; 21: 819-831 [PMID: 22500582 DOI: 10.1517/13543784.2012.681045]
21. Wang YM, Jin BZ, Ai F, Duan CH, Lu YZ, Dong TF, Fu QL. The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials. Cancer Chemother Pharmacol 2012; 69: 1213-1220 [PMID: 22271210 DOI: 10.1007/ s00280-012-1828-8]
22. Seely D, Wu P, Fritz H, Kennedy DA, Tsui T, Seely AJ, Mills E. Melatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trials. Integr Cancer Ther 2012; 11: 293-303 [PMID: 22019490 DOI: 10.1177/1534735411425484]
23. Kroemer G, Mariño G, Levine B. Autophagy and the integrated stress response. Mol Cell 2010; 40: 280-293 [PMID: 20965422 DOI: 10.1016/j.molcel.2010.09.023]
24. Hubbard VM, Valdor R, Macian F, Cuervo AM. Selective autophagy in the maintenance of cellular homeostasis in aging organisms. Biogerontology 2012; 13: 21-35 [PMID: 21461872 DOI: 10.1007/s10522-011-9331-x]
25. Jung CH, Ro SH, Cao J, Otto NM, Kim DH. mTOR regulation of autophagy. FEBS Lett 2010; 584: 1287-1295 [PMID: 20083114 DOI: 10.1016/j.febslet.2010.01.017]
26. Ramírez-Valle F, Braunstein S, Zavadil J, Formenti SC, Schneider RJ. eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy. J Cell Biol 2008; 181: 293-307 [PMID: 18426977 DOI: 10.1083/jcb.200710215]
27. Pattingre S, Espert L, Biard-Piechaczyk M, Codogno P. Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie 2008; 90: 313-323 [PMID: 17928127 DOI: 10.1016/j.biochi.2007.08.014]
28. Lorin S, Pierron G, Ryan KM, Codogno P, Djavaheri-Mergny M. Evidence for the interplay between JNK and p53-DRAM signalling pathways in the regulation of autophagy. Autophagy 2010; 6: 153-154 [PMID: 19949306 DOI: 10.4161/auto.6.1.10537]
29. Hoeijmakers JH. Genome maintenance mechanisms are critical for preventing cancer as well as other aging-associated diseases. Mech Ageing Dev 2007; 128: 460-462 [PMID: 17588642 DOI: 10.1016/j.mad.2007.05.002]
30. Friedberg EC. How nucleotide excision repair protects against cancer. Nat Rev Cancer 2001; 1: 22-33 [PMID: 11900249 DOI: 10.1038/35094000]
31. Mayo JC, Sainz RM, Antoli I, Herrera F, Martin V, Rodriguez C. Melatonin regulation of antioxidant enzyme gene expression. Cell Mol Life Sci 2002; 59: 1706-1713 [PMID: 12475181 DOI: 10.1007/PL00012498]
32. Rodriguez C, Mayo JC, Sainz RM, Antolín I, Herrera F, Martín V, Reiter RJ. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36: 1-9 [PMID: 14675124 DOI: 10.1046/j.1600-079X.2003.00092.x]
33. Blask DE, Sauer LA, Dauchy RT. Melatonin as a chronobiotic/ anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadianbased cancer therapy. Curr Top Med Chem 2002; 2: 113-132 [PMID: 11899096 DOI: 10.2174/1568026023394407]
34. Rodriguez-Rocha H, Garcia-Garcia A, Panayiotidis MI, Franco R. DNA damage and autophagy. Mutat Res 2011; 711: 158-166 [PMID: 21419786 DOI: 10.1016/j.mrfmmm.2011.03.007]
35. Sancar A, Lindsey-Boltz LA, Unsal-Kaçmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004; 73: 39-85 [PMID: 15189136 DOI: 10.1146/annurev.biochem. 73.011303.073723]
36. Ding WX, Li M, Chen X, Ni HM, Lin CW, Gao W, Lu B, Stolz DB, Clemens DL, Yin XM. Autophagy reduces acute ethanol-induced hepatotoxicity and steatosis in mice. Gastroenterology 2010; 139: 1740-1752 [PMID: 20659474 DOI: 10.1053/j.gastro.2010.07.041]
37. Bowden NA, Ashton KA, Avery-Kiejda KA, Zhang XD, Hersey P, Scott RJ. Nucleotide excision repair gene expression after Cisplatin treatment in melanoma. Cancer Res 2010; 70: 7918-7926 [PMID: 20807809 DOI: 10.1158/0008-5472. CAN-10-0161]
38. Slee EA, O'Connor DJ, Lu X. To die or not to die: how does p53 decide? Oncogene 2004; 23: 2809-2818 [PMID: 15077144 DOI: 10.1038/sj.onc.1207516]
39. Sengupta S, Harris CC. p53: traffic cop at the crossroads of DNA repair and recombination. Nat Rev Mol Cell Biol 2005; 6: 44-55 [PMID: 15688066 DOI: 10.1038/nrm1546]
40. Seo YR, Jung HJ. The potential roles of p53 tumor suppressor in nucleotide excision repair (NER) and base excision repair (BER). Exp Mol Med 2004; 36: 505-509 [PMID: 15665582 DOI: 10.1038/emm.2004.64]
41. Andrieux LO, Fautrel A, Bessard A, Guillouzo A, Baffet G, Langouët S. GATA-1 is essential in EGF-mediated induction of nucleotide excision repair activity and ERCC1 expression through ERK2 in human hepatoma cells. Cancer Res 2007; 67: 2114-2123 [PMID: 17332341 DOI: 10.1158/0008-5472. CAN-06-3821]
42. Steffensen KD, Waldstrøm M, Jakobsen A. The relationship of platinum resistance and ERCC1 protein expression in epithelial ovarian cancer. Int J Gynecol Cancer 2009; 19: 820-825 [PMID: 19574766 DOI: 10.1111/IGC.0b013e3181a12e09]